EUVIMEDOpdag EUVIMED
Crossref

Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne

James Q Del Rosso, Leon Kircik

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.7863 ↗

At a glance

Journal article in Journal of Drugs in Dermatology, 2024. Written by James Q Del Rosso and 1 co-authors. Major MEDLINE topics: Isotretinoin, Acne Vulgaris, Dermatologic Agents.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

INTRODUCTION: Micronized isotretinoin 0.4 to 0.8 mg/kg/day administered in 2 divided doses with or without meals is approved for the treatment of severe nodular acne in patients aged 12 years or older. Although practitioners may suggest once-daily dosing to increase patient compliance, supporting data are limited. METHODS: In this pilot study, patients aged 12 years or older with severe nodular acne (Investigator's Global Assessment [IGA] =>4 and >5 facial nodules) received once-daily micronized isotretinoin 0.4 to 0.8 mg/kg/day without food for 20 weeks. The coprimary efficacy endpoints were changes from baseline in nodular lesion count (NLC) and percentage of patients with a =>90% reduction in NLC at week 24. Secondary endpoints included percentage of patients achieving IGA 0/1; reductions in inflammatory lesion count (ILC) and noninflammatory lesion count (NILC); adverse events (AEs); and severity of erythema, dryness, peeling, oiliness, burning, and pruritus. Analyses included all enrolled patients with the last observation carried forward. RESULTS: Twenty-two of 24 patients completed the study. From baseline to week 24, NLC decreased by a median (quartile [Q]1, Q3) of 6 (5, 7), all patients experienced complete clearance of nodules, 23/24 (96%) patients achieved IGA 0/1, and ILC and NILC decreased by a mean +/- standard deviation of 97.8% +/- 5.7% and 98.4% +/- 6.2%, respectively (all P

Subjects

MeSH terms (MEDLINE)

IsotretinoinAcne VulgarisDermatologic AgentsHumansMaleFemalePilot ProjectsAdolescentTreatment OutcomeAdultYoung AdultDrug Administration ScheduleChildSeverity of Illness IndexAdministration, Cutaneous

Substances

IsotretinoinDermatologic Agents

Cite

APA

Del Rosso, J. Q., & Kircik, L. (2024). Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7863

Vancouver

Del Rosso JQ, Kircik L. Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7863

BibTeX
@article{DelRosso2024,
  author = {Del Rosso, James Q and Kircik, Leon},
  title = {Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.7863}
}
Start for free →